IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques (Q43953909)

28 November 2017

IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques (English)

1 reference

Simian immunodeficiency virus

28 November 2017

0 references

author name string

Boyer JD

1

1 reference

28 November 2017

Nath B

2

1 reference

28 November 2017

Schumann K

3

1 reference

28 November 2017

Curley E

4

1 reference

28 November 2017

Manson K

5

1 reference

28 November 2017

Kim J

6

1 reference

28 November 2017

Weiner DB

7

1 reference

28 November 2017

1 May 2002

1 reference

International Journal for Parasitology

28 November 2017

1 reference

28 November 2017

32

1 reference

28 November 2017

5

1 reference

28 November 2017

543-550

1 reference

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Impaired interleukin 12 production in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

The IL4- induced switch of CD8+ T cells to a TH2 phenotype and its possible relationship to the onset of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Immune control of HIV-1 after early treatment of acute infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900355-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7519(01)00355-1

1 reference

28 November 2017

1 reference